Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer’s disease

References

• AarslandDZaccaiJBrayneC2005A systematic review of prevalence studies of dementia in Parkinson’s diseaseMovement Disord2012556316041803
   PubMed Web of Science ®Google Scholar
• AtkinsonASingletonABStewardA1999CYP2D6 is associated with Parkinson’s disease but not with dementia with Lewy bodies or Alzheimer’s diseasePharmacogenetics931510208640
   PubMedGoogle Scholar
• BarkerWMLuisCAKashubaA2002Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida brain bankAlzheimer Dis Assoc Disord162031212468894
   PubMed Web of Science ®Google Scholar
• BenjaminRLeakeAEdwardsonJA1994Apolipoprotein E genes in Lewy body and Parkinson’s diseaseLancet34315657911882
   PubMed Web of Science ®Google Scholar
• Bertoli-AvellaAMOostraEBAHeutinkEP2004Chasing genes in Alzheimer’s and Parkinson’s diseaseHum Genet1144133814999561
   PubMed Web of Science ®Google Scholar
• BollerFMizutaniTRoessmannU1980Parkinson’s disease, dementia, and Alzheimer’s disease: clinicopathological correlationsAnnals Neurol732935
   PubMed Web of Science ®Google Scholar
• BordetRBrolyFDesteeA1994Genetic polymorphism of cytochrome P450 2D6 in idiopathic Parkinson disease and diffuse Lewy body diseaseClin Neuropharmacol1748489316701
   PubMed Web of Science ®Google Scholar
• BowerJHMaraganoreDMPetersonBJ2003Head trauma preceding PD: a case-control studyNeurology601610512771250
   PubMed Web of Science ®Google Scholar
• BraakHBraakE1991Neuropathological stageing of Alzheimer-related changesActa Neuropathol82239591759558
   PubMed Web of Science ®Google Scholar
• BraakHDel TrediciKRubU2003Staging of brain pathology related to sporadic Parkinson’s diseaseNeurobiol Aging2419721112498954
   PubMed Web of Science ®Google Scholar
• BraakHRubUJansen SteurEN2005Cognitive status correlates with neuropathologic stage in Parkinson diseaseNeurology6414041015851731
   PubMed Web of Science ®Google Scholar
• BurkhardtCRFilleyCMKleinschmidt-deMastersB1988Diffuse Lewy body disease and progressive dementiaNeurology38152082843793
   PubMed Web of Science ®Google Scholar
• CelesiaGGWanamakerWM1972Psychatric disturbances in Parkinson’s diseaseDis Nervous Sys3357783
   PubMedGoogle Scholar
• ChenHZhangSMHernanMA2003Nonsteroidal anti-inflammatory drugs and the risk of Parkinson diseaseArch Neurol6010596412925360
   PubMed Web of Science ®Google Scholar
• ChenHZhangSMSchwarzschildMA2005Physical activity and the risk of Parkinson diseaseNeurology64664915728289
   PubMed Web of Science ®Google Scholar
• CombarrosOLlorcaJSánchez-GuerraM2003Age-dependent association between interleukin-1A (−889) genetic polymorphism and sporadic Alzheimer’s disease. A meta-analysisJ Neurol250987912928921
   PubMed Web of Science ®Google Scholar
• DodelRCLohmullerFDuY2001A polymorphism in the intronic region of the IL-1alpha gene and the risk for Parkinson’s diseaseNeurology56982311294947
   PubMed Web of Science ®Google Scholar
• FornoLSBarbourPJNorvilleRL1978Presenile dementia with Lewy bodies and neurofibrillary tanglesArch Neurol3581822718484
   PubMedGoogle Scholar
• FurunoTKawanishiCIsekiE2001No evidence of an association between CYP2D6 polymorphisms among Japanese and dementia with Lewy bodiesPsychiatry Clin Neurosci55899211285084
   PubMed Web of Science ®Google Scholar
• GalaskoDSaitohTXiaY1994The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer’s diseaseNeurology44195017936253
   PubMed Web of Science ®Google Scholar
• GraeberMBMuellerU2003Dementia with Lewy bodies: disease concept and geneticsNeurogenetics41576212898286
   PubMed Web of Science ®Google Scholar
• GriffinWSTStanleyLCLingC1989Brain interleukin-1 and S100 immunoreactivity are elevated in Alzheimer disease and in Down syndromeProc Natl Acad Sci USA86761152529544
   PubMed Web of Science ®Google Scholar
• GriffinWSTShengJGRobertsGW1995Interleukin-1 expression in different plaque types in Alzheimer’s disease, significance in plaque evolutionJ Neuropathol Exp Neurol54276817876895
   PubMed Web of Science ®Google Scholar
• GriffinWSTLiuLLiY2006Interleukin-1 mediates Alzheimer and Lewy body pathologiesJ Neuroinflammation3516542445
   PubMed Web of Science ®Google Scholar
• HakimAMathiesonG1979Dementia in Parkinson’s disease: A neuropathological studyNeurology29120914573401
   PubMed Web of Science ®Google Scholar
• HansenLAMasliahEGalaskoD1993Plaque-only Alzheimer’s disease is usually the Lewy body variant, and vice versaJ Neuropathol Exp Neurol6648548229084
   PubMed Web of Science ®Google Scholar
• HernanMATakkoucheBCaamano-IsornaF2002A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s diseaseAnn Neurol522768412205639
   PubMed Web of Science ®Google Scholar
• HobsonPMearaJ2004Risk and incidence of dementia in a cohort of older subjects with Parkinson’s disease in the United KingdomMovement Disord191043915372593
   PubMed Web of Science ®Google Scholar
• IkedaKIkedaSYoshimuraT1978Idiopathic Parkinsonism with Lewy-type inclusions in cerebral cortex. A case reportActa Neuropathol411658205083
   PubMed Web of Science ®Google Scholar
• IkedaKHoriABodeG1980Progressive dementia with “diffuse Lewy-type inclusions” in cerebral cortex. A case reportArchiv fur Psychiatrie Nervenkrankheiten2282438
   Google Scholar
• KambohMI2004Molecular genetics of late-onset Alzheimer’s diseaseAnnals Human Genetics68381404
   PubMed Web of Science ®Google Scholar
• KuzuharaSMoriHIzumiyamaN1988Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical studyActa Neuropathol75345533364159
   PubMed Web of Science ®Google Scholar
• LeeAJ1985Parkinson’s disease and dementiaLancetI434
   Google Scholar
• LennoxGLoweJMorrellK1989Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body diseaseJ Neurol Neurosurg Psychiatry5267712540286
   PubMed Web of Science ®Google Scholar
• LiYLiuLBargerSW2003Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathwayJ Neurosci2316051112629164
   PubMed Web of Science ®Google Scholar
• LiebermannADziatolowskiMCoopersmithM1979Dementia in Parkinson’s diseaseAnn Neurol63559554525
   PubMed Web of Science ®Google Scholar
• MattilaKMRinneJOLehtimakiT2002Association of an interleukin 1B gene polymorphism (−511) with Parkinson’s disease in Finnish patientsJ Med Gen394002
   PubMed Web of Science ®Google Scholar
• MayeuxRSternYSpantonS1985Heterogeneity in dementia of the Alzheimer type: evidence of subgroupsNeurology35453613982631
   PubMed Web of Science ®Google Scholar
• McGeerPLYasojimaKMcGeerEG2002Association of interleukin-1 beta polymorphisms with idiopathic Parkinson’s diseaseNeurosci Lett32667912052540
   PubMed Web of Science ®Google Scholar
• McKeithIGGalaskoDKosakaK1996Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshopNeurology471113248909416
   PubMed Web of Science ®Google Scholar
• McKeithIGDicksonDWLoweJ2005Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB ConsortiumNeurology6518637216237129
   PubMed Web of Science ®Google Scholar
• MirraSSHeymanAMcKeelD1991The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s diseaseNeurology41479862011243
   PubMed Web of Science ®Google Scholar
• MollerJCDepboyluCKolschH2004Lack of association between the interleukin-1 alpha (−889) polymorphism and early-onset Parkinson’s diseaseNeurosci Lett359195715050696
   PubMed Web of Science ®Google Scholar
• MolsaPKMarttilaRJRinneUK1984Extrapyramidal signs in Alzheimer’s diseaseNeurology34111466540392
   PubMed Web of Science ®Google Scholar
• NishimuraMMizutaIMizutaE2000Influence of interleukin-1beta gene polymorphisms on age-at-onset of sporadic Parkinson’s diseaseNeurosci Lett28473610771165
   PubMed Web of Science ®Google Scholar
• NishimuraMKunoSKajiR2005Glutathione-S-transferase-1 and interleukin-1beta gene polymorphisms in Japanese patients with Parkinson’s diseaseMovement Disord20901215834859
   PubMed Web of Science ®Google Scholar
• OkazakiHLipkinLEAronsonSM1961Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexionJ Neuropathol Exp Neurol202374413730588
   PubMed Web of Science ®Google Scholar
• PerlDPOlanowCWCalneD1998Alzheimer’s disease and Parkinson’s disease: distinct entities or extremes of a spectrum of neurodegeneration?Ann Neurol44S19319749570
   PubMed Web of Science ®Google Scholar
• PollackMHornabrookRW1966The prevalence, natural history, and dementia of Parkinson’s diseaseBrain89429485921126
   PubMed Web of Science ®Google Scholar
• RaineroIFerreroMBMValfrèW2004Association between the interleukin-1alpha gene and Alzheimer’s disease: a meta-analysisNeurobiol Aging251293815465625
   PubMed Web of Science ®Google Scholar
• RosenbergCKCummingsTJSaundersAM2001Dementia with Lewy bodies and Alzheimer’s diseaseActa Neuropathol102621611761723
   PubMed Web of Science ®Google Scholar
• SaitohTXiaYChenX1995The CYP2D6B mutant allele is over-represented in the Lewy body variant of Alzheimer’s diseaseAnn Neurol3711027818242
   PubMed Web of Science ®Google Scholar
• SchulteTScholsLMullerT2002Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson’s diseaseNeurosci Lett32670212052541
   PubMed Web of Science ®Google Scholar
• ScottWKGrubberJMConneallyPM2000Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneityAmer J Human Genet669223210712207
   PubMed Web of Science ®Google Scholar
• SerrettiAArtioliPQuartesanR2005Genes involved in Alzheimer’s disease, a survey of possible candidatesJ Alzheimer’s Dis733153
   Web of Science ®Google Scholar
• ShengJGMrakREGriffinWS1995Microglial interleukin-1alpha expression in brain regions in Alzheimer’s disease: Correlation with neuritic plaque distributionNeuropathol Appl Neurobiol212903017494597
   PubMed Web of Science ®Google Scholar
• ShengJGMrakREGriffinWS1997Glial-neuronal interactions in Alzheimer’s disease: Progressive association of IL-1alpha + microglia and S100beta + astrocytes with neurofibrillary tangle stagesJ Neuropathol Exp Neurol56285909056542
   PubMed Web of Science ®Google Scholar
• ShengJGZhuSGJonesRA2000Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivoExp Neurol1633889110833312
   PubMed Web of Science ®Google Scholar
• ShengJGJonesRAZhouXQ2001Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer’s disease: potential significance for tau protein phosphorylationNeurochem Int39341811578769
   PubMed Web of Science ®Google Scholar
• SpillantiniMGSchmidtMLLeeVM1997Alpha-synuclein in Lewy bodiesNature388839409278044
   PubMed Web of Science ®Google Scholar
• The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease1997Consensus recommendations for the postmortem diagnosis of Alzheimer’s diseaseNeurobiol Aging18Suppl 4S129330978
   PubMedGoogle Scholar
• WakabayashiKMatsumotoKTakayamaK1997NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson’s diseaseNeurosci Lett2394589547168
   PubMed Web of Science ®Google Scholar
• YagishitaSItohYAmanoN1980Atypical senile dementia with widespread Lewy type inclusion in the cerebral cortexActa Neuropathol49187916245556
   PubMed Web of Science ®Google Scholar
• ZhangSMHernanMAChenH2002Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD riskNeurology591161912391343
   PubMed Web of Science ®Google Scholar